Диссертация (1140273), страница 29
Текст из файла (страница 29)
– 2010. – Vol.25. – №1. – P.67-74.88.Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: newinsights in signaling, development, and disease // J. Cell Biol. – 2006. – Vol.172. – №7. –P.973-81.89.Lee M.H., Cheong J.Y., Um S.H., Seo Y.S., Kim D.J., Hwang S.G., et al. Comparison ofsurrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis inpatients with chronic viral hepatitis // Dig Dis Sci. – 2010. – Vol.55.
– №12. – P.3552-60.90.Loaeza-del-Castillo A., Paz-Pineda F., Oviedo-Cárdenas E., Sánchez-Avila F., VargasVorácková F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liverfibrosis // Ann Hepatol. – 2008. – Vol.7. – №4. – P.350-7.91.Lucidarme D., Foucher J., Le Bail B., Vergniol J., Castera L., Duburque C., et al. Factors ofaccuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronichepatitis C // Hepatology.
– 2009. – Vol.49. – №4. – P.1083-9. 92.136 Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructivecholangitis (syndrome of primary biliary cirrhosis) // Virchows Arch A Pathol Pathol Anat. –1978. – Vol.379. – №2. – P.103–112.93.Lupsor M., Badea R., Stefanescu H., Sparchez Z., Branda H., Serban A., et al. Performance ofa new elastographic method (ARFI technology) compared to unidimensional transientelastography in the noninvasive assessment of chronic hepatitis C. Preliminary results // JGastrointestin Liver Dis.
– 2009. – Vol.18. – №3 – P.303–310.94.Mallat A., Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liverfibrosis // Am J Physiol Cell Physiol. – 2013. – Vol.305. – №8. – P.789-99.95.Mangone M., Moretti A., Alivernini F., Papi C., Orefice R., Dezi A., et al. Plateletcount/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful incompensated cirrhosis? // Dig Liver Dis.
– 2012. – Vol.44. – №6. – P. 504-7.96.Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., VierlingJ,M,; American Association for the Study of Liver Diseases. Diagnosis and management ofautoimmune hepatitis // Hepatology. – 2010. – Vol.51. – №6.
– P.2193-213.97.Marcellin P., Ziol M., Bedossa P., Douvin C., Poupon R., de Ledinghen V., et al. Noninvasive assessment of liver fibrosis by stiffness measurement in patients with chronichepatitis B // Liver Int. – 2009. – Vol.29. – №2. – P.242–247.98.Marra F., Tacke F. Roles for chemokines in liver disease // Gastroenterology. – 2014. –Vol.147. – №3. – P.577–594.99.Martin J., Khatri G., Gopal P., Singal AG. Accuracy of Ultrasound and Noninvasive Markersof Fibrosis to Identify Patients with Cirrhosis // Digestive Diseases and Sciences. – 2015. –Vol.60. – №6.
– P.1841-1847.100.Mayo MJ, Parkes J., Adams-Huet B., et al. Prediction of Clinical Outcomes in PrimaryBiliary Cirrhosis by Serum Enhanced Liver Fibrosis (ELF) Assay // Hepatology. – 2008. –Vol.48. – №5. - P.1549–1557.101.McHugh M.L. Interrater reliability: the kappa statistic // Biochem Med (Zagreb). – 2012. –Vol.22. – №3. – P.276–282.102.McPherson S., Stewart SF., Henderson E., et al. Simple non-invasive fibrosis scoring systemscan reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease // Gut.– 2010.
– Vol.59. – №9. – P.1265-9.103.Meng Y., Liang Y., and Liu M. The Value of MRI in the Diagnosis of Primary BiliaryCirrhosis and Assessment of Liver Fibrosis // PLoS One. – 2015. – Vol.10. – №3. –e0120110.104.Millonig G., Friedrich S., Adolf S., Fonouni H., Golriz M., Mehrabi A., et al. Liver stiffness 137 is directly influenced by central venous pressure // J Hepatol.
– 2010. – Vol.52. – №2. –Р.206-10.105.Mokdad A.A., Lopez A.D., Shahraz S., Lozano R., Mokdad A.H., Stanaway J., et. al. Livercirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis // BMCMed. – 2014. – Vol.12. – №145. – P.1-24.106.Myers R.P., Pomier-Layrargues G., Kirsch R., Pollett A., Beaton M., Levstik M., et al.Discordance in fibrosis staging between liver biopsy and transient elastography using theFibroScan XL probe // J Hepatol.
– 2012. – Vol.56. – №3. – Р.564-70.107.Myers R.P., Pomier-Layrargues G., Kirsch R., Pollett A., Duarte-Rojo A., Wong D., et al.Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffnessmeasurement in overweight and obese patients // Hepatology. – 2012. – Vol.55.
– №1. –Р.199-208.108.Nierhoff J., Chavez Ortiz A.A., Herrmann E., Zeuzem S., Friedrich-Rust M. The efficiency ofacoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis //Eur Radiol. – 2013. – Vol.23. – №11 – P.3040–3053.109.Nyblom H., Björnsson E., Simrén M., et al. The AST/ALT ratio as an indicator of cirrhosis inpatients with PBC // Liver Int.
– 2006. – Vol.26. – №7. – P.840-5.110.Palmeri M.L., Wang M.H., Rouze N.C., Abdelmalek M.F., Guy C.D., Moser B., et al.Noninvasive evaluation of hepatic fibrosis using acoustic radiation forcebased shear stiffnessin patients with nonalcoholic fatty liver disease // J Hepatol 2011. – Vol.55. – №3. – P.666–672.111.Parkes J., Guha I.N., Roderick P., Harris S., Cross R., Manos M.M., et al. Enhanced LiverFibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C // JViral Hepat. – 2011. – Vol.18.
– №1. – Р.23-31.112.Pavlov C.S., Casazza G., Nikolova D., Tsochatzis E., Burroughs A.K., Ivashkin V.T., GluudC. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in peoplewith alcoholic liver disease // Cochrane Database Syst Rev. – 2015: CD010542.113.Pavlov C.S., Casazza G., Nikolova D., Tsochatzis E., Burroughs A.K., Ivashkin V.T., GluudC. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in peoplewith alcoholic liver disease // Cochrane Database Syst Rev. – 2015.:CD010542.114.Pellicoro A., Ramachandran P., Iredale J.P., Fallowfield J.A. Liver fibrosis and repair:immune regulation of wound healing in a solid organ // Nat Rev Immunol. – 2014.
– Vol.14 –№3. – с.181–194.115.Pinzani M., Rombouts K., Colagrande S. Fibrosis in chronic liver diseases: diagnosis andmanagement // J Hepatol. – 2005. – Vol.42. – Suppl(1). – P.22-36. 116.138 Pissaia A., Borderie Jr. D., Bernard D., Scatton O., Calmus Y., and Conti F. APRI and FIB-4Scores Are Useful After Liver Transplantation Independently of Etiology // Transplant Proc.– 2009. – Vol.41. – №2. – P.679-81.117.Popov Y., Patsenker E., Stickel F., Zaks J., Bhaskar K.R., Niedobitek G., et al.
Integrinalphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a noveltarget for antifibrotic therapies // J Hepatol. – 2008. – Vol.48. – №3. – P.453-64.118.Poynard T., Halfon P., Castera L., Munteanu M., Imbert-Bismut F., Ratziu V., et al.Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers basedon prevalences of fibrosis stages // Clin Chem. – 2007.
– Vol.53. – №9. – P.1615-22.119.Poynard T., Munteanu M., Imbert-Bismut F., et al. Prospective analysis of discordant resultsbetween biochemical markers and biopsy in patients with chronic hepatitis C // Clin Chem. –2004. – Vol.50. – P.1344-1355.120.Righi S., Fiorini E., Molo C. De, et al. ARFI elastography in patients with chronicautoimmune liver diseases: A preliminary study // J Ultrasound. – 2012. –Vol.15. – №4. –P.226-31.121.Rizzo L., Calvaruso V., Cacopardo B., Alessi N., Attanasio M., Petta S., et al. Comparison oftransient elastography and acoustic radiation force impulse for non-invasive staging of liverFibrosis in patients with chronic hepatitis C // Am J Gastroenterol.
– 2011. – Vol.106. – №12.– P.2112–2120.122.Rockey D.C., Caldwell S.H., Goodman Z.D., Nelson R.C., Smith A.D.; AmericanAssociation for the Study of Liver Diseases. Liver biopsy // Hepatology. – 2009. – Vol.49. –№3. – P.1017-44.123.Rockey Don C. and Bissell D. Montgomery. Noninvasive Measures of Liver Fibrosis //Hepatology. – 2006. – Vol.43.
– P.113-120.124.Schiavon Lde L., Narciso-Schiavon J.L., de Carvalho-Filho R.J. Non-invasive diagnosis ofliver fibrosis in chronic hepatitis C // World J Gastroenterol. – 2014. – Vol.20. – №11. –Р.2854-66.125.Sharma S., Khalili K., Nguyen G.C. Non-invasive diagnosis of advanced fibrosis andcirrhosis // World J Gastroenterol. – 2014. – Vol.20. – №45. – P.16820-30.126.Soresi M., Giannitrapani L., Cervello M., Licata A., Montalto G. Non invasive tools for thediagnosis of liver cirrhosis // World J Gastroenterol.
– 2014. – Vol.20. – №48. – P.18131-50.127.Sterling R.K., Lissen E., Clumeck N. Development of a simple non invasive index to predictsignificant fibrosis in patients with HIV/HCV coinfection. Hepatology – 2006. – Vol.43. –№6 – P.1317–25.128.Svegliati-Baroni G., De Minicis S., Marzioni M. Hepatic fibrogenesis in response to chronic 139 liver injury: novel insights on the role of cell-to-cell interaction and transition // Liver Int. –2008. – Vol.28. – №8.
– P.1052-64.129.Tacke F., Zimmermann H.W. Macrophage heterogeneity in liver injury and fibrosis // JHepatol. – 2014. – Vol.60. – №5. – P.1090–1096.130.Testa R., Testa E., Giannini E., Borro P., Milazzo S., Isola L., et al. Noninvasive ratio indexesto evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratioindex // J Intern Med. – 2006. – Vol.260. – №2.
– P.142-50.131.Trautwein C., Friedman S.L., Schuppan D., Pinzani M. Hepatic fibrosis: Concept to treatment// J Hepatol. – 2015. – Vol.62. – Suppl. – P.S15-24.132.Trivedi PJ., Bruns1 T., Cheung A., et al. Optimising risk stratification in primary biliarycirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acidresponse // J Hepatol. – 2014. – Vol.60. – №6. – P.1249-58133.Troeger J.S., Mederacke I., Gwak G.Y., Dapito D.H., Mu X., Hsu C.C., et al. Deactivation ofhepatic stellate cells during liver fibrosis resolution in mice // Gastroenterology. – 2012. –Vol.143. – №4.
– P.1073–1083.134.Voumvouraki A., Koulentaki M., Notas G., et al. Serum surrogate markers of liver fibrosis inprimary biliary cirrhosis // Eur J Intern Med. – 2011. – Vol.22. – №1. – P.77-83.135.Way C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., etal. A simple non invasive index can predict both significant fibrosis and cirrhosis in patientswith chronic hepatitis C // Hepatology. – 2003. – Vol.38. – №2 – P.518–26.136.Xu J., Liu X., Koyama Y., Wang P., Lan T., Kim I.G., et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
